Recent advances in the field of endoscopy have found fertile ground for application in inflammatory bowel diseases (IBD). Mucosal healing is a primary goal of IBD therapy, and current evidence shows that histologic remission (HR) is an additional desirable outcome. However, with the use of standard endoscopy, a considerable number of patients with histologically active disease go unrecognized. This narrative article examines the role, current or potential, of each endoscopic technique, from standard white-light endoscopy to molecular imaging, in the assessment of mucosal healing and HR in IBD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.giec.2024.04.008 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!